Mechanisms Regulating Muscle Protein Synthesis in CKD

J Am Soc Nephrol. 2020 Nov;31(11):2573-2587. doi: 10.1681/ASN.2019121277. Epub 2020 Aug 6.

Abstract

Background: CKD induces loss of muscle proteins partly by suppressing muscle protein synthesis. Muscles of mice with CKD have increased expression of nucleolar protein 66 (NO66), as do muscle biopsy specimens from patients with CKD or those undergoing hemodialysis. Inflammation stimulates NO66 expression and changes in NF-κB mediate the response.

Methods: Subtotal nephrectomy created a mouse model of CKD with BUN >80 mg/dl. Crossing NO66flox/flox with MCK-Cre mice bred muscle-specific NO66 (MCK-NO66) knockout mice. Experiments assessed the effect of removing NO66.

Results: Muscle-specific NO66 knockout in mice blocks CKD-induced loss of muscle mass and improves protein synthesis. NO66 suppression of ribosomal biogenesis via demethylase activity is the mechanism behind these responses. In muscle cells, expression of NO66, but not of demethylase-dead mutant NO66, decreased H3K4me3 and H3K36me3 and suppressed pre-rRNA expression. Knocking out NO66 increased the enrichment of H3K4me3 and H3K36me3 on ribosomal DNA. In primary muscle cells and in muscles of mice without NO66, ribosomal RNA, pre-rRNA, and protein synthesis all increased.

Conclusions: CKD suppresses muscle protein synthesis via epigenetic mechanisms that NO66 mediates. Blocking NO66 could suggest strategies that counter CKD-induced abnormal muscle protein catabolism.

Keywords: chronic kidney disease; epigenetics; muscle wasting; protein metabolism; protein synthesis; ribosomal RNA transcription.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Animals
  • Cell Line
  • DNA, Ribosomal
  • Dioxygenases / genetics
  • Dioxygenases / metabolism*
  • Disease Models, Animal
  • Epigenesis, Genetic
  • Female
  • Gene Expression
  • Histone Demethylases / genetics
  • Histone Demethylases / metabolism*
  • Histones / genetics
  • Humans
  • Interferon-gamma / pharmacology
  • Interleukin-6 / genetics
  • Interleukin-6 / pharmacology
  • Jumonji Domain-Containing Histone Demethylases / genetics*
  • Male
  • Mice
  • Mice, Knockout
  • Middle Aged
  • Muscle Fibers, Skeletal / metabolism*
  • Muscle Fibers, Skeletal / pathology*
  • Muscle Proteins / genetics
  • NF-kappa B / metabolism
  • Nephrectomy
  • Protein Biosynthesis / genetics*
  • RNA, Messenger / metabolism
  • Renal Dialysis
  • Renal Insufficiency, Chronic / complications*
  • Renal Insufficiency, Chronic / therapy
  • SKP Cullin F-Box Protein Ligases / genetics
  • Signal Transduction
  • Tripartite Motif Proteins / genetics
  • Tumor Necrosis Factor-alpha / pharmacology
  • Ubiquitin-Protein Ligases / genetics

Substances

  • DNA, Ribosomal
  • Histones
  • IL6 protein, human
  • Interleukin-6
  • Muscle Proteins
  • NF-kappa B
  • RNA, Messenger
  • Tripartite Motif Proteins
  • Tumor Necrosis Factor-alpha
  • histone H3 trimethyl Lys4
  • Interferon-gamma
  • Dioxygenases
  • Histone Demethylases
  • Jumonji Domain-Containing Histone Demethylases
  • nucleolar protein 66, mouse
  • RIOX1 protein, human
  • FBXO32 protein, human
  • SKP Cullin F-Box Protein Ligases
  • TRIM63 protein, human
  • Ubiquitin-Protein Ligases